|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
Actavis UK
AstraZeneca_products
|
|
gptkbp:awards
|
Innovation Award 2021
Excellence in Manufacturing 2019
Best_Pharma_Company_2020
|
|
gptkbp:certifications
|
gptkb:MHRA
gptkb:FDA
EMA
|
|
gptkbp:employees
|
Over 1000
|
|
gptkbp:established
|
2015
|
|
gptkbp:financials
|
Revenue over $1 billion
Profit_margin_20%
|
|
gptkbp:focus
|
Cardiology
Gastroenterology
Oncology
Diabetes
Neurology
Infectious diseases
Respiratory
|
|
gptkbp:founded
|
gptkb:Intas_Pharmaceuticals_Ltd.
|
|
gptkbp:headquarters
|
gptkb:United_Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Intas Pharma (UK) Ltd.
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:market
|
gptkb:Asia
gptkb:North_America
Europe
|
|
gptkbp:parentCompany
|
gptkb:Intas_Pharmaceuticals_Ltd.
|
|
gptkbp:partnerships
|
Various global partners
|
|
gptkbp:products
|
Branded drugs
Generic_drugs
|
|
gptkbp:researchAndDevelopment
|
Yes
|
|
gptkbp:socialResponsibility
|
Sustainability programs
Community health initiatives
Employee welfare programs
|
|
gptkbp:subsidiary
|
gptkb:Intas_Pharmaceuticals_Canada
gptkb:Intas_Pharmaceuticals_Australia
gptkb:Intas_Pharmaceuticals_USA
gptkb:Intas_Pharmaceuticals_Europe
gptkb:Intas_Pharmaceuticals_India
gptkb:Intas_Pharmaceuticals_Middle_East
gptkb:Intas_Pharmaceuticals_Africa
Intas_Pharmaceuticals_Latin_America
|
|
gptkbp:website
|
www.intaspharma.com
|